8:15 to 8:45 a.m.
8:50 to 9:00 a.m.
Welcome, Steven Rosen, M.D., Provost, City of Hope
9:00 to 10:00 a.m.
Spatial Systems Biology of Cancer
Joe Gray, Ph.D., Knight Cancer Institute, University of Oregon Health and Science University
10:00 to 10:15 a.m.
10:15 to 11:15 a.m.
Doxorubicin-induced Cardiotoxicity: SUMO, Ubiquitin, and Topoisomerase 2b
Edward T.H. Yeh, M.D., University of Texas MD Anderson Cancer Center
11:15 a.m. to 12:15 p.m.
Epigenetic Regulation of Acute Leukemia Initiation and Progression Iannis Aifantis, Ph.D., Howard Hughes Medical Institute and NYU School of Medicine
12:15 to 1:15 p.m.
1:15 to 2:15 p.m.
Tissue Force, Tumor Progression and Treatment
Valerie Weaver, Ph.D., University of California, San Francisco
2:15 to 3:15 p.m.
Drugging the Undruggable Ras: Mission Possible?
Channing Der, Ph.D., Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill
3:15 to 3:30 p.m.
3:30 to 4:30 p.m.
Oncogenic Ras Signaling: From Biology to Therapeutics
Dafna Bar-Sagi, Ph.D., NYU Langone Medical Center
4:30 to 5:30 p.m.
A β3 Integrin-KRAS-RalB Complex Drives Tumor Stemness and Resistance to EGFR Inhibition
David Cheresh, Ph.D., Moores Cancer Center, University of California, San Diego